RE:RE:RE:RE:Soon 99942: Not sure I agree with you about “soon.” Unfortunately, I did not speak with the company – I am relying on a couple of posters who said they had been told there would be a news release “soon.” “Soon” suggests within a couple of weeks. If the company knowledge is, in fact, so limited, perhaps it would be better to disavow all attempts at prediction and simply say: “We have no information at the moment. We have decided to scrap the newsletter. We will, of course, release any information about the progress of the company as soon as it becomes available.” That would indicate that they are waiting for information over which they have no control. They should avoid words which lead to reasonable, but doomed expectations.
I will confess that my little diatribe is a reflection of an annoyance built up over a number of years. (I am now so old a shareholder that 70-year-old ladies give up their seats to me on the bus. Or they would -- if I could make it to the bus stop.)
You hold out some tantalizing prospects – of the kind which no long-term Theralase shareholder can afford to entertain. We have become used to disappointment, and know the folly of optimistic expectations.
Yes, one day – perhaps even this year – we will see news of positive clinical results, official FDA encouragement, and some move in the direction (I am being so cautious) of a clinical trial for a different type of cancer. And that might involve some kind of partnership. One day – as a result of such events – the stock price might go up. A little bit. But I am going to avoid the word “soon.”
–Idel Dreimer